Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/1999
08/05/1999WO1999038929A1 An article having a surface showing adhesive properties
08/05/1999WO1999038853A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999WO1999038542A1 A synthetic biomaterial compound
08/05/1999WO1999038536A1 Absorbable microparticles
08/05/1999WO1999038535A1 Process for making absorbable microparticles
08/05/1999WO1999038528A2 Vaccine formulations
08/05/1999WO1999038527A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
08/05/1999WO1999038522A1 Herbal anti-viral agent
08/05/1999WO1999038518A2 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/05/1999WO1999038517A1 Compositions for oral treatment of warts
08/05/1999WO1999038513A1 R-lansoprazole compositions and methods
08/05/1999WO1999038512A1 S-lansoprazole compositions and methods
08/05/1999WO1999038511A1 Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations
08/05/1999WO1999038506A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
08/05/1999WO1999038505A1 Compositions for prevention and treatment of cold and influenza-like symptoms associated with respiratory tract infections
08/05/1999WO1999038504A1 Pharmaceutical uses of optically pure (-)-bupropion
08/05/1999WO1999038503A1 Pharmacological uses of optically pure (+)-bupropion
08/05/1999WO1999038502A1 Pharmaceutical uses of optically pure (+)-bupropion
08/05/1999WO1999038499A2 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
08/05/1999WO1999038496A1 Fast dissolving pharmaceutical products
08/05/1999WO1999038495A2 Controlled release delivery of peptide or protein
08/05/1999WO1999038493A1 Microparticle inhalation formulations
08/05/1999WO1999038492A1 Nasal solutions
08/05/1999WO1999038472A2 Topical vasodilatory gel composition and methods of use and production
08/05/1999WO1999022763A3 Encapsulated immunomodulators useful as vaccine adjuvants
08/05/1999WO1999017740A9 Peptide/lipid complex formation by co-lyophilization
08/05/1999WO1999007349A3 Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
08/05/1999WO1995031429A8 Photocleavable agents and conjugates for the detection and isolation of biomolecules
08/05/1999CA2335037A1 Aqueous compositions comprising complexing agents and uses thereof
08/05/1999CA2320963A1 R-lansoprazole compositions and methods
08/05/1999CA2320902A1 S-lansoprazole compositions and methods
08/05/1999CA2319711A1 Vaccine
08/05/1999CA2319629A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone
08/05/1999CA2319514A1 Spray drying of pharmaceutical formulations containing amino acid-based materials
08/05/1999CA2319411A1 Herbal anti-viral agent
08/05/1999CA2319202A1 Preparation for treatment of erectile dysfunction
08/05/1999CA2318960A1 Pharmaceutical uses of optically pure (+)-bupropion
08/05/1999CA2318921A1 Pharmacological uses of optically pure (+)-bupropion
08/05/1999CA2318920A1 Pharmaceutical uses of optically pure (-)-bupropion
08/05/1999CA2318738A1 Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
08/05/1999CA2318513A1 Process for making absorbable microparticles
08/05/1999CA2318443A1 Synergistic mixtures of garlic and lycopene for preventing ldl oxidation
08/05/1999CA2318152A1 Absorbable microparticles
08/04/1999EP0933084A1 Aqueous composition containing cromoglycic acid
08/04/1999EP0933081A1 Pharmaceutical compositions containing mupirocin
08/04/1999EP0933079A1 Free-flowable, directly compressible starch as binder, disintegrant and filler for compression tablets and hard gelatine capsules
08/04/1999EP0932410A1 Mistletoe (viscum) extracts
08/04/1999EP0932404A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
08/04/1999EP0932397A2 Medicinal aerosol formulations comprising budesonide
08/04/1999EP0932396A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
08/04/1999EP0932395A1 Methods and compositions employing red yeast fermentation products
08/04/1999EP0932394A1 Vitamin delivery
08/04/1999EP0932393A1 Solid foamed active substance preparations
08/04/1999EP0932392A1 Method for inducing a systemic immune response to an antigen
08/04/1999EP0932391A2 Fusogenic liposome composition and method
08/04/1999EP0932390A1 Therapeutic liposome composition and method
08/04/1999EP0932389A1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum
08/04/1999EP0932388A2 Dosage form and method for administering drug
08/04/1999EP0932360A1 Biocide impregnated fibre reinforced sponge material
08/04/1999EP0814805A4 Process and products for reducing biological fluid levels of a lipid soluble waste
08/04/1999EP0808153B1 Method and device for administering analgesics
08/04/1999EP0789558B1 Use of liquid fluorocarbons to facilitate pulmonary drug delivery
08/04/1999EP0774954B1 Hydrogel for the application of therapeutic and/or cosmetic active substances to the skin
08/04/1999EP0757554B1 Lollipop with tooth plaque neutralising effect
08/04/1999EP0744895B1 Adherent disinfecting compositions and methods relating thereto
08/04/1999EP0585242B1 Wound healing
08/04/1999EP0538437B1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
08/04/1999CN1225017A Quickly disintegrable compression-molded materials and process for producing the same
08/04/1999CN1225008A Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
08/04/1999CN1225007A Cationic virosomes as transfer system for genetic material
08/04/1999CN1224621A Rotavirus resisting immune globulin composite and its preparation and use
08/04/1999CN1224619A Novel powder compositions
08/04/1999CN1224615A Salvia plebeia extract and its use
08/04/1999CN1224610A Ibuprofen compositions
08/04/1999CN1224608A Production of medical health dressing
08/04/1999CA2256942A1 Human growth hormone-containing aqueous pharmaceutical composition
08/03/1999US5932765 Nitromethyl ketones, process for preparing them and compositions containing them
08/03/1999US5932602 Treatment of platelet derived growth factor related disorders such as cancers
08/03/1999US5932597 Anaesthetic formulation
08/03/1999US5932589 Oral drug
08/03/1999US5932563 Methods for treating spinal cord injury
08/03/1999US5932562 Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
08/03/1999US5932560 Treatment of conditions and disease
08/03/1999US5932553 Illudin analogs useful as antitumor agents
08/03/1999US5932547 Non-aqueous polar aprotic peptide formulations
08/03/1999US5932536 Compositions for neutralization of lipopolysaccharides
08/03/1999US5932471 DNA encoding chimeric toxin
08/03/1999US5932460 Method and apparatus for sealing implantable, membrane encapsulation devices containing living cells
08/03/1999US5932459 Artificial tissues, methods for the production and the use thereof
08/03/1999US5932427 In vitro assay system for identifying compositions useful for stimulating B cells
08/03/1999US5932249 Budesonide pellets with a controlled released pattern and process for producing the same
08/03/1999US5932248 Ionic polymer matrix
08/03/1999US5932247 Microcrystalline cellulose, lactose and pregelatinized starch; gelatin; croscarmellose sodium
08/03/1999US5932245 Gelatin or collagen hydrolysate containing drug formulation that provides for immediate release of nanoparticle drug compounds
08/03/1999US5932244 Liposomal human calcitonin gene-related peptide composition and preparation of the same
08/03/1999US5932243 Galenical formulations
08/03/1999US5932242 Anticarcinogenic agents, antiinflammatory agents
08/03/1999US5932241 Cationic lipid DNA complexes for gene targeting
08/03/1999US5932240 Multidose transdermal drug delivery system
08/03/1999US5932239 Transdermal therapeutic system with protection against hydrolysis
1 ... 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 ... 2991